Home
>
National Drug Code (NDC)
>
Pamidronate Disodium
Pamidronate Disodium - 61703-325-18 - (PAMIDRONATE DISODIUM)
Drug Information of Pamidronate Disodium
| Product NDC: | 61703-325 |
| Proprietary Name: | Pamidronate Disodium |
| Non Proprietary Name: | PAMIDRONATE DISODIUM |
| Active Ingredient(s): | 6 mg/mL & nbsp; PAMIDRONATE DISODIUM |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Pamidronate Disodium
| Product NDC: | 61703-325 |
| Labeler Name: | Hospira Worldwide, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075841 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110609 |
Package Information of Pamidronate Disodium
| Package NDC: | 61703-325-18 |
| Package Description: | 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-325-18) > 10 mL in 1 VIAL, SINGLE-DOSE |
NDC Information of Pamidronate Disodium
| NDC Code | 61703-325-18 |
| Proprietary Name | Pamidronate Disodium |
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-325-18) > 10 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 61703-325 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | PAMIDRONATE DISODIUM |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20110609 |
| Marketing Category Name | ANDA |
| Labeler Name | Hospira Worldwide, Inc. |
| Substance Name | PAMIDRONATE DISODIUM |
| Strength Number | 6 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |
